IGHG3 and Guillain-Barre syndrome: In patients with GBS, the occurrence of T-cell-dependent IgG1 and IgG3 anti-ganglioside antibodies indicates the presence of reactive T-cells that could disrupt the blood–nerve barrier, contributing to the acute onset and severity of the disease.